Amlan International Launches Two New Natural Alternatives to Antibiotics for Poultry and Livestock
27 April 2022 - 11:40PM
The removal of in-feed antibiotics from poultry and livestock
production has left a huge gap in the protection of animals from
the devastating effects of enteric disease. To help producers
recapture this protection, Amlan International, the animal health
business of Oil-Dri® Corporation of America, has launched two new
natural products — Phylox® Feed and NeutraPath® — that help
optimize intestinal health and production economics in the absence
of antibiotics.
Phylox Feed is a natural alternative to anticoccidial drugs and
vaccines that can help producers increase profitability.
Coccidiosis, caused by Eimeria species, is an enteric disease that
can have a significant economic impact on animal protein
production. The synergistic blend of bioactive phytochemicals in
Phylox work together with multiple modes of action to damage
Eimeria cell structure and function while strengthening intestinal
integrity and boosting immunity. Phylox can be effective for
full-time use or in rotation, and/or in a bio-shuttle program when
resistance is a concern. In addition, Phylox does not need to be
withdrawn from feed prior to slaughter. Phylox is an ideal solution
for all poultry species, including broilers, egg layers and broiler
breeders, all of which can be sensitive to fungal and bacterial
toxins during grow-out and egg production when exposed to fecal
oocysts that are being shed as coccidia cycle. Research has shown
that Phylox can be fed concurrently with anticoccidial vaccines,
preventing disease breakthrough while immunity is being developed
by the bird without interfering with vaccine
efficacy.
“The most important goal for producers is to keep animals
healthy. Producers grow animals to a certain size, and they don’t
want to lose them in the last few days of their growth
development,” said Fred Kao, VP of Global Sales for Amlan. “The
launch of Phylox and NeutraPath will be a huge benefit to the
animal protein industry. Animals can remain healthy and reach their
full potential, naturally.”
NeutraPath is a natural pathogen control product for
antibiotic-free production that uses multiple modes of action to
increase livability and improve feed conversion. Using a
proprietary and co-active blend of essential oils, fatty acids and
Amlan’s proprietary mineral technology, NeutraPath reduces
pathogenic bacterial load and colonization, and improves intestinal
health and structural integrity, all of which contribute to
improved performance and increased production yields.
“Managing enteric disease without antibiotics has placed extra
pressure on nutritionists and veterinarians to find natural
solutions that can achieve the same level of performance observed
with antibiotic use,” said Dr. Wade Robey, VP of Marketing and
Product Development for Amlan. “NeutraPath has answered the call
for a natural product that targets pathogens and the toxins they
produce — and it improves intestinal health, as well. It’s the
natural alternative to antibiotics that the animal protein industry
has been waiting for.”
NeutraPath can be used to protect the intestinal health of all
livestock species. The Journal of Animal Science recently published
a study by UC Davis researchers on the effects of NeutraPath in
weaned pigs challenged with enterotoxigenic E. coli. NeutraPath
reduced the incidence of severe diarrhea, enhanced feed efficiency
during the last week of the study and modified fecal and ileal
mucosa microbiota diversity.
Both of the new products can be used individually or in a
program with Amlan’s mineral-based products, like Calibrin®-Z and
patented Varium® and NeoPrime®, to help support gut health and
improve productivity and efficiency.
Phylox and NeutraPath are commercially available in select
international markets. While not available for sale in the United
States, North American customers interested in NeutraPath and
Phylox can contact Amlan for more information on similar feed
additives available in the U.S. that were developed to optimize
intestinal health in production animals.
Amlan invests heavily in R&D to produce well-validated
products both in vitro and in animals, and they are also working
directly with customers to assess the commercial performance of
their new products. Producers interested in testing the products
for themselves can contact Amlan at info@amlan.com.
Company Information
Amlan is the animal health business of Oil-Dri Corporation of
America, leading global manufacturer and marketer of sorbent
minerals. Oil-Dri leverages over 80 years of expertise in mineral
science to selectively mine and process their unique mineral for
consumer and business-to-business markets. Oil-Dri Corporation of
America doing business as “Amlan International” is a publicly
traded stock on the New York Stock Exchange (NYSE: ODC). Amlan
International sells feed additives across the world. Product
availability may vary by country; associated claims do not
constitute medical claims and may differ based on government
requirements.
Reagan CulbertsonMedia Contactpress@amlan.com
Oil Dri Corp of America (NYSE:ODC)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Oil Dri Corp of America (NYSE:ODC)
Historical Stock Chart
Von Apr 2023 bis Apr 2024